Drilldown: Medicines

Codeine (2)

Other values:

Search

None (12) · (multiple, generic dominant) (1) · Alfenta (1) · Aptiom (1) · Banzel (1) · Briviact (1) · Cerebyx (1) · Darvon (1) · Demerol (1) · Depakote (1) · Diacomit (1) · Dilantin (1) · Dilaudid (1) · Duragesic (1) · Epidiolex (1) · Felbatol (1) · Fintepla (1) · Flagyl, Metrocream, Metrogel, Metrogel-Vaginal, Noritate (1) · Fycompa (1) · Gabitril (1) · Heroin (1) · Krokodil (1) · Luminal (1) · Nubain (1) · Nucynta (1) · O-DSMT (1) · Onfi (1) · Opana (1) · Sabril (1) · Stablon (1) · Stadol (1) · Sufenta (1) · Talwin (1) · Ultiva (1) · Vicodin (1) · Vimpat (1) · Xcopri (1) · Zarontin (1) · Zonegran (1)

Research material · Classic Psychedelic · Stimulant · Opioid · Sedative-Hypnotic · Phenethylamine · Tryptamine · Benzodiazepine · Botanical · [[:Category:Antihypertensives|Antihypertensive]] · Dissociative · Anticonvulsant · Antidepressant · Plant Medicine · Analgesic · Antiparkinsonian · Antipsychotic · Empathogen · Neuroleptic · Cathinone

Other values:

Search

Potent mu-opioid receptor agonist (6) · Mu-opioid receptor agonist (4) · Sodium channel blocker (2)

Other values:

Search

None (48) · Mild to moderate pain; cough suppression (low-dose). (1) · '"`UNIQ--vote-00000BE3-QINU`"', '"`UNIQ--vote-00000BE4-QINU`"', '"`UNIQ--vote-00000BE5-QINU`"', '"`UNIQ--vote-00000BE6-QINU`"', '"`UNIQ--vote-00000BE7-QINU`"', '"`UNIQ--vote-00000BE8-QINU`"', '"`UNIQ--vote-00000BE9-QINU`"', '"`UNIQ--vote-00000BEA-QINU`"' (1)

None (48) · 500 mg PO TID × 7-10 days (most indications); 2 g single dose for trichomoniasis; 500 mg IV q8h for severe anaerobic infection; rectal 1 g BID (1) · Adult: 15–60 mg every 4 hours as needed. (1)

None (48) · 250, 500 mg tablets; 750 mg ER; 500 mg/100 mL IV; 0.75-1% topical gel/cream; 0.75% vaginal gel; suppository (1) · Tablet (15, 30, 60 mg); oral solution; combination products (with [[Acetaminophen|acetaminophen]] or ibuprofen). (1)

None (48) · 360 mg/day (1) · ~4 g/d (severe systemic infection) (1)

None (48) · IV (1) · Oral (1) · PO (only formulation marketed in the US). (1) · topical (1) · vaginal (1)

None (48) · 30–60 min (PO) (1) · Hours (1)

None (48) · 4–6 hours (1) · 8-12 hours (1)

None (48) · 2.5–3 hours (1) · 6-8 hours'"`UNIQ--ref-00000BEB-QINU`"' (1)

None (48) · ~50% (variable, CYP2D6-dependent for analgesic effect). (1) · ~80% (oral)'"`UNIQ--ref-00000BEC-QINU`"' (1)

None (48) · Avoid; risk of neonatal opioid withdrawal with chronic use; UM-mother breastfeeding contraindicated. (1) · Generally considered safe after the first trimester; first-trimester use weighed against indication.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1)

None (48) · US Schedule II (single-entity); Schedule III–V (combination products by content). (1) · [[USLegal:Prescription only|Rx-only]] in US (1)